TelyRx Holdings Inc. (TELY) Stock Price & Analysis
TELY Stock Chart & Stats
CA$2.45CA$0.05(2.08%)
At close: 9:40 AM EST
- Day’s Range
- CAD 2.44 - CAD 2.45
- 52-Week Range
- CAD 2.00 - CAD 4.25
- Previous Close
- CAD 2.40
- Volume
- N/A
- Average Volume (3M)
- 6,891
- Market Cap
- CAD 64.32M
- Enterprise Value
- CAD 103.50M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- -0.07
- Next Earnings
- Nov 05, 2026 (Est.)
- EPS Estimate
- -0.04
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
TelyRx Holdings Inc. News
TelyRx Revenue Surges 143% as Digital Pharmacy Platform Scales Customer Base
TelyRx Holdings Inc. ( ($TSE:TELY) ) has shared an update. TelyRx Holdings Inc., a technology-enabled healthcare and digital pharmacy platform, connects patients with independent, state-licensed providers who prescribe treatments that
2M agoTELY
TELY FAQ
What was TelyRx Holdings Inc.’s price range in the past 12 months?
TelyRx Holdings Inc. lowest stock price was C$2.00 and its highest was C$4.25 in the past 12 months.
What is TelyRx Holdings Inc.’s market cap?
TelyRx Holdings Inc.’s market cap is C$64.32M.
When is TelyRx Holdings Inc.’s upcoming earnings report date?
TelyRx Holdings Inc.’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 1 day.
How were TelyRx Holdings Inc.’s earnings last quarter?
TelyRx Holdings Inc. released its earnings results on Aug 10, 2026. The company reported -C$0.126 earnings per share for the quarter, missing the consensus estimate of -C$0.056 by -C$0.07.
Is TelyRx Holdings Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does TelyRx Holdings Inc. pay dividends?
TelyRx Holdings Inc. does not currently pay dividends.
What is TelyRx Holdings Inc.’s EPS estimate?
TelyRx Holdings Inc.’s EPS estimate is -0.04.
How many shares outstanding does TelyRx Holdings Inc. have?
TelyRx Holdings Inc. has 26,798,004 shares outstanding.
What happened to TelyRx Holdings Inc.’s price movement after its last earnings report?
TelyRx Holdings Inc. reported an EPS of -C$0.126 in its last earnings report, missing expectations of -C$0.056. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of TelyRx Holdings Inc.?
Currently, no hedge funds are holding shares in TSE:TELY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TelyRx Holdings Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
TelyRx Holdings Inc.
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Vanessa Slowey
- Website
- telyrx.com
- Address
- 24761 US Hwy 19N, Clearwater, FL, 33763, US
TelyRx Holdings Inc. (TELY) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 7 |
| Technical Analysis | 3 | 5 | 1 |
| Moving Averages | 6 | 0 | 6 |
